Methylene Blue Dosage, half-life & reference guide

Also known as MB · Methylthioninium chloride · ProvayBlue · Methylene blue USP

Reviewed Evidence: EmergingPublished by PepVault

A blue dye and old hospital drug, approved by IV for a blood disorder (methemoglobinemia). Biohackers take small oral doses on the idea that it helps mitochondria make energy. One small trial found a single dose brightened brain activity and slightly improved short-term memory; a related compound failed in Alzheimer disease, and mice in the NIA's program did not live longer on it. Its label warns of serotonin syndrome with antidepressants.

Studied range
35–280 mg
How often
Daily
Half-life
~24 hours
Evidence
●●● Emerging
Routes
Oral, IV injection

Studied in research — not a recommendation. FDA-approved (ProvayBlue) as IV treatment for acquired methemoglobinemia; oral nootropic use is off-label.

How it works.

Methylene blue is a blue dye and an old drug. It accepts and passes on electrons, which is how it treats methemoglobinemia, the condition the FDA approved it for, and why it is thought to act as a backup electron carrier in mitochondria, the idea behind its use as a nootropic and longevity aid. Its label carries a boxed warning: combined with serotonin-acting drugs, it can cause serotonin syndrome. In a small trial, one oral dose brightened brain activity on fMRI and slightly improved memory an hour later. A related compound failed a large Alzheimer trial, and mice in the NIA's program did not live longer on it.

Commonly reported: Blue urine, and for some a clearer head.

Half-life & active level

The half-life of Methylene Blue is ~24 hours (FDA label, ProvayBlue); about 72% of an oral dose reaches the blood (Walter-Sack 2009).

Here's how a typical Methylene Blue schedule accumulates over a week (one-compartment estimate).

An estimate from the half-life above, not a measurement. See your own curve build live in the half-life calculator.

Your report

Taken Methylene Blue? What did you notice?

One tap to start. About 30 seconds, no account.

A smiling woman with silver hair in a grey training top by a window, holding her phone

PepVault for iPhone

Track Methylene Blue in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week.

What to expect in the first 8 weeks

Onset
About an hour (one-dose fMRI trial)
Peak effect
Not established
Duration
No long-term trials of the low-dose use
  1. Day 1–3Clinical

    Blue urine is the expected sign

    Methylene blue is a dye, and the body clears it into the urine, so blue or green urine is normal and harmless. Its label notes it can confuse urine dipstick tests, worth mentioning before one.

    The science

    ProvayBlue label (DailyMed, Jun 2025): a blue dye that passes freely into the urine and may interfere with urine tests relying on a blue indicator, such as the leucocyte esterase dipstick; half-life about 24 hours. Walter-Sack 2009: oral bioavailability 72.3% (500 mg oral vs 50 mg IV in 16 adults).

    Sources
    • FDA label, ProvayBlue (2025)
    • Walter-Sack et al. (2009)

    Updated Nov 2026

  2. Day 1–14RCT

    A sharper hour, in one small trial

    In a placebo-controlled trial, one oral dose made the brain work harder on attention and memory tasks on fMRI an hour later, and memory recall improved by 7%. That is a single dose in 26 people, not long-term use.

    The science

    Rodriguez 2016 (Radiology): 26 healthy adults aged 22–62, 280 mg (about 4 mg/kg) USP methylene blue or placebo; 1 hour later, bilateral insular response during a psychomotor vigilance task (P = .01–.008) and prefrontal, parietal and occipital response in short-term memory tasks rose; correct memory-retrieval responses +7% (P = .01).

    Sources
    • Rodriguez et al. (2016)

    Updated Nov 2026

  3. Day 1–30Clinical

    The one combination to know

    Methylene blue interacts with serotonin-acting drugs. Beside an SSRI, SNRI, MAO inhibitor or certain opioids, that can tip into serotonin syndrome, which is why the label puts it in a boxed warning. Anyone on those medicines checks with their prescriber first.

    The science

    ProvayBlue label: boxed warning, serious or fatal serotonergic syndrome with serotonergic drugs and opioids; avoid SSRIs, SNRIs and MAOIs (and the other drugs listed). Contraindicated in G6PD deficiency because of severe hemolysis. Ng 2010 (Psychosomatics) is a systematic review of methylene blue in serotonin syndrome.

    Sources
    • FDA label, ProvayBlue (2025)
    • Ng et al. (2010)

    Updated Nov 2026

  4. Any dayRCT

    What methylene blue is built on

    Methylene blue is a well-known hospital drug with a clear label. As a longevity or brain supplement, the evidence is thin: one single-dose fMRI trial, a failed Alzheimer trial of a related compound, and no lifespan gain in the NIA's mice.

    The science

    Gauthier 2016 (Lancet, NCT01689246): 891 people with mild to moderate Alzheimer disease, LMTM 75 or 125 mg twice daily vs a 4 mg control for 15 months; no benefit on ADAS-Cog or ADCS-ADL. Harrison 2014 (ITP): no change in median lifespan in either sex; female maximum lifespan +6% (P = 0.004).

    Sources
    • Gauthier et al. (2016)
    • Harrison et al. (2014)

    Updated Nov 2026

  5. With NAD+ and CoQ10Community

    A mitochondria stack built on theory

    Methylene blue is often paired with NAD+ or CoQ10 on the idea that all three support the mitochondria's energy chain at different steps. No study has tested these combinations in people.

    The science

    Methylene blue cycles between oxidised and reduced forms and can pass electrons in the respiratory chain (the redox mechanism behind its label use in methemoglobinemia). CoQ10 is the chain's own electron carrier. The stacks are community practice.

    Sources
    • FDA label, ProvayBlue (2025)

    Updated Nov 2026

Day 1 is the day you start it.

The ProvayBlue FDA label (DailyMed, Jun 2025); one small single-dose fMRI RCT; a large negative phase 3 trial of a related compound; the ITP; an oral PK study.

Preliminary research

A typical run.

Run notes

Cycle
The trials gave single doses (fMRI study) or 15 months of a related compound (LMTM, Alzheimer disease). No trial has tested daily low-dose methylene blue for aging.Community practice — opinions vary. Not a clinical recommendation.
Timing
The fMRI trial measured effects one hour after a single oral dose, taken after a light meal and without caffeine.
Routes
Oral (off-label), IV injection (label, hospital)
Stacks
NAD+, CoQ10

Track it in the app

Safety.

Common side effects

  • Blue-green urine (expected)
  • Dry mouth
  • Lower abdominal pain
  • Palpitations (listed for the drug class)

Interactions

The label's boxed warning names SSRIs, SNRIs, MAO inhibitors and other serotonergic drugs and opioids: the combination can cause serotonin syndrome. People with G6PD deficiency should not take it (label contraindication). Discuss every medication with your clinician.

Safety notes

A prescription drug, approved as an IV treatment for acquired methemoglobinemia at 1 mg/kg; oral use for cognition or aging is off-label. Its boxed warning is serious: with SSRIs, SNRIs, MAO inhibitors, some other antidepressants and opioids it can cause serotonin syndrome, which can be fatal, so the label says to avoid those combinations. It is contraindicated in G6PD deficiency, where it can destroy red blood cells. Reduced kidney function raises blood levels. It turns urine blue-green and can disturb urine dipstick tests. Discuss with your clinician before use, and never beside an antidepressant without them.

Goes with.

Questions people ask.

What is Methylene Blue?

A blue dye and old hospital drug, approved by IV for a blood disorder (methemoglobinemia). Biohackers take small oral doses on the idea that it helps mitochondria make energy. One small trial found a single dose brightened brain activity and slightly improved short-term memory; a related compound failed in Alzheimer disease, and mice in the NIA's program did not live longer on it. Its label warns of serotonin syndrome with antidepressants.

How is Methylene Blue dosed in research?

The research range for Methylene Blue is 35–280 mg, daily. Studied in research — not a recommendation. FDA-approved (ProvayBlue) as IV treatment for acquired methemoglobinemia; oral nootropic use is off-label.

How long does Methylene Blue last?

The half-life of Methylene Blue is ~24 hours (FDA label, ProvayBlue); about 72% of an oral dose reaches the blood (Walter-Sack 2009).

What do people report on Methylene Blue?

Commonly reported on Methylene Blue: blue urine, and for some a clearer head.

Is Methylene Blue safe?

The research basis for Methylene Blue is emerging: primarily preclinical / limited human data. Common side effects in the library: blue-green urine (expected), dry mouth, lower abdominal pain and palpitations (listed for the drug class).

What does Methylene Blue stack with?

Common stacks for Methylene Blue: NAD+ and CoQ10.

Track it in the app

Research.

The literature

Search the latest research

Reference.

Cadence

Daily

Half-life

~24 hours

~24 hours (FDA label, ProvayBlue); about 72% of an oral dose reaches the blood (Walter-Sack 2009)

Research basis

●●● Emerging

Primarily preclinical / limited human data

PepVault for iPhone

Track Methylene Blue in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo

Reviewed How we check the library